Your browser doesn't support javascript.
loading
Thromboembolism Incidence and Risk Factors in Multiple Myeloma After First Exposure to Immunomodulatory Drug-Based Regimens.
Patel, Jai N; Robinson, Myra; Jagosky, Megan; Slaughter, Daniel; Arnall, Justin; Jandrisevits, Elizabeth; Matusz-Fisher, Ashley; Atrash, Shebli; Paul, Barry; Bhutani, Manisha; Voorhees, Peter; Usmani, Saad Z.
Afiliación
  • Patel JN; Department of Cancer Pharmacology, Levine Cancer Institute/Atrium Health, Charlotte, NC. Electronic address: jai.patel@atriumhealth.org.
  • Robinson M; Department of Biostatistics, Levine Cancer Institute/Atrium Health, Charlotte, NC.
  • Jagosky M; Division of Plasma Cell Disorders, Levine Cancer Institute/Atrium Health, Charlotte, NC.
  • Slaughter D; Department of Biostatistics, Levine Cancer Institute/Atrium Health, Charlotte, NC.
  • Arnall J; Department of Pharmacy, Levine Cancer Institute/Atrium Health, Charlotte, NC.
  • Jandrisevits E; Department of Cancer Pharmacology, Levine Cancer Institute/Atrium Health, Charlotte, NC.
  • Matusz-Fisher A; Department of Biostatistics, Levine Cancer Institute/Atrium Health, Charlotte, NC.
  • Atrash S; Division of Plasma Cell Disorders, Levine Cancer Institute/Atrium Health, Charlotte, NC.
  • Paul B; Division of Plasma Cell Disorders, Levine Cancer Institute/Atrium Health, Charlotte, NC.
  • Bhutani M; Division of Plasma Cell Disorders, Levine Cancer Institute/Atrium Health, Charlotte, NC.
  • Voorhees P; Division of Plasma Cell Disorders, Levine Cancer Institute/Atrium Health, Charlotte, NC.
  • Usmani SZ; Division of Plasma Cell Disorders, Levine Cancer Institute/Atrium Health, Charlotte, NC.
Clin Lymphoma Myeloma Leuk ; 21(3): 188-198.e2, 2021 03.
Article en En | MEDLINE | ID: mdl-33339769

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Tromboembolia / Protocolos de Quimioterapia Combinada Antineoplásica / Antineoplásicos Inmunológicos / Mieloma Múltiple Tipo de estudio: Diagnostic_studies / Etiology_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Clin Lymphoma Myeloma Leuk Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Tromboembolia / Protocolos de Quimioterapia Combinada Antineoplásica / Antineoplásicos Inmunológicos / Mieloma Múltiple Tipo de estudio: Diagnostic_studies / Etiology_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Clin Lymphoma Myeloma Leuk Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article